Physician profile
Brittney Davis
NPI 1770101594
$159.74
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.75 · 2023: $63.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $22.54 | 2022 | |
| Lilly USA, LLC | $17.82 | 2023 | Emgality, Reyvow |
| Exact Sciences Corporation | $16.88 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $16.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.06 | 2022 | |
| Lucid Diagnostics INC. | $15.06 | 2022 | |
| Merck Sharp & Dohme LLC | $14.89 | 2023 | Steglatro, Belsomra |
| Novo Nordisk INC | $14.40 | 2023 | Rybelsus, Ozempic |
| Abbvie INC. | $13.78 | 2022 | |
| Exeltis, USA INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.